Substandard Cancer Drugs Plague Africa: One in Six Found Defective

A shocking study reveals a widespread problem of substandard cancer drugs in several African countries. Researchers tested nearly 200 cancer drugs from hospitals and pharmacies in Ethiopia, Kenya, Malawi, and Cameroon, finding that roughly 17% had insufficient active ingredients, including drugs used in major hospitals. This could lead to tumor growth and spread. The study points to weak drug regulation in Africa, highlighting the need for stronger oversight, improved testing technologies, and training. While most drugs met standards, a few bad actors pose a significant health risk.
Read more